HealthInvest Partners AB
Latest statistics and disclosures from HealthInvest Partners AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MRK, LLY, UNH, TMO, NBIX, and represent 36.53% of HealthInvest Partners AB's stock portfolio.
- Added to shares of these 10 stocks: MRK (+$9.0M), NBIX, LLY, OPCH, MIRM, FOLD, UNH, TMO, IMCR, ITCI.
- Started 5 new stock positions in CRBP, MRSN, MGNX, NAMS, MIRM.
- Reduced shares in these 10 stocks: , BMY, COR, CI, GILD, CAH, PFE, ELV, Ambrx Biopharma, .
- Sold out of its positions in BMY, CI, CNC, Ambrx Biopharma, PFE, PRTA.
- HealthInvest Partners AB was a net buyer of stock by $24M.
- HealthInvest Partners AB has $164M in assets under management (AUM), dropping by 28.65%.
- Central Index Key (CIK): 0001381843
Tip: Access up to 7 years of quarterly data
Positions held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 44 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Merck & Co (MRK) | 10.7 | $18M | +103% | 134k | 131.95 |
|
| Eli Lilly & Co. (LLY) | 9.8 | $16M | +31% | 21k | 777.96 |
|
| UnitedHealth (UNH) | 6.9 | $11M | +25% | 23k | 494.70 |
|
| Thermo Fisher Scientific (TMO) | 5.4 | $8.8M | +33% | 15k | 581.21 |
|
| Neurocrine Biosciences (NBIX) | 3.6 | $6.0M | +244% | 44k | 137.92 |
|
| Harmony Biosciences Hldgs In (HRMY) | 3.5 | $5.7M | +17% | 170k | 33.58 |
|
| Stryker Corporation (SYK) | 3.3 | $5.4M | +18% | 15k | 357.87 |
|
| Amgen (AMGN) | 3.3 | $5.4M | +17% | 19k | 284.32 |
|
| Abbvie (ABBV) | 3.3 | $5.3M | +38% | 29k | 182.10 |
|
| Boston Scientific Corporation (BSX) | 3.2 | $5.3M | +19% | 77k | 68.49 |
|
| Regeneron Pharmaceuticals (REGN) | 3.2 | $5.2M | +35% | 5.4k | 962.49 |
|
| AmerisourceBergen (COR) | 3.0 | $5.0M | -47% | 20k | 242.99 |
|
| Molina Healthcare (MOH) | 3.0 | $4.9M | -4% | 12k | 410.83 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $4.7M | +23% | 11k | 418.01 |
|
| Option Care Health Com New (OPCH) | 2.7 | $4.5M | +257% | 133k | 33.54 |
|
| Anthem (ELV) | 2.3 | $3.8M | -22% | 7.4k | 518.54 |
|
| Gilead Sciences (GILD) | 2.3 | $3.8M | -47% | 52k | 73.25 |
|
| Dex (DXCM) | 2.2 | $3.6M | +45% | 26k | 138.70 |
|
| Mirum Pharmaceuticals (MIRM) | 1.9 | $3.1M | NEW | 123k | 25.12 |
|
| Cardinal Health (CAH) | 1.9 | $3.1M | -42% | 28k | 111.90 |
|
| Amicus Therapeutics (FOLD) | 1.8 | $3.0M | +417% | 252k | 11.78 |
|
| Fusion Pharmaceuticals (FUSN) | 1.8 | $3.0M | +11% | 139k | 21.32 |
|
| Ionis Pharmaceuticals (IONS) | 1.7 | $2.8M | +163% | 64k | 43.35 |
|
| Immunocore Hldgs Ads (IMCR) | 1.6 | $2.7M | +422% | 41k | 65.00 |
|
| Intra Cellular Therapies (ITCI) | 1.6 | $2.6M | +210% | 38k | 69.20 |
|
| Iqvia Holdings (IQV) | 1.5 | $2.5M | -2% | 10k | 252.89 |
|
| Edwards Lifesciences (EW) | 1.4 | $2.4M | +19% | 25k | 95.56 |
|
| Shockwave Med (SWAV) | 0.9 | $1.5M | +34% | 4.8k | 325.63 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.9 | $1.5M | NEW | 38k | 39.24 |
|
| Cabaletta Bio (CABA) | 0.8 | $1.3M | +269% | 78k | 17.06 |
|
| Arcellx Common Stock (ACLX) | 0.7 | $1.2M | +53% | 18k | 69.55 |
|
| Krystal Biotech (KRYS) | 0.7 | $1.2M | 6.6k | 177.93 |
|
|
| Bridgebio Pharma (BBIO) | 0.7 | $1.2M | +57% | 38k | 30.92 |
|
| EXACT Sciences Corporation (EXAS) | 0.7 | $1.1M | +32% | 16k | 69.06 |
|
| Merus N V (MRUS) | 0.7 | $1.1M | 24k | 45.03 |
|
|
| Inspire Med Sys (INSP) | 0.6 | $1.0M | +48% | 4.8k | 214.79 |
|
| Cytokinetics Com New (CYTK) | 0.6 | $982k | +19% | 14k | 70.11 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $945k | +39% | 3.5k | 267.04 |
|
| Macrogenics (MGNX) | 0.4 | $726k | NEW | 49k | 14.72 |
|
| Akero Therapeutics (AKRO) | 0.4 | $617k | +58% | 24k | 25.26 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $615k | 96k | 6.38 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $530k | NEW | 22k | 23.65 |
|
| Morphic Hldg (MORF) | 0.3 | $526k | 15k | 35.20 |
|
|
| Mersana Therapeutics (MRSN) | 0.3 | $448k | NEW | 100k | 4.48 |
|
Past Filings by HealthInvest Partners AB
SEC 13F filings are viewable for HealthInvest Partners AB going back to 2013
- HealthInvest Partners AB 2024 Q1 filed April 25, 2024
- HealthInvest Partners AB 2023 Q4 filed Jan. 30, 2024
- HealthInvest Partners AB 2022 Q4 filed Feb. 14, 2023
- HealthInvest Partners AB 2022 Q3 filed Oct. 21, 2022
- HealthInvest Partners AB 2022 Q2 filed July 8, 2022
- HealthInvest Partners AB 2022 Q1 filed May 5, 2022
- HealthInvest Partners AB 2021 Q4 filed Jan. 18, 2022
- HealthInvest Partners AB 2021 Q3 filed Nov. 8, 2021
- HealthInvest Partners AB 2021 Q2 filed Aug. 10, 2021
- HealthInvest Partners AB 2021 Q1 filed April 30, 2021
- HealthInvest Partners AB 2020 Q4 filed Feb. 5, 2021
- HealthInvest Partners AB 2017 Q4 filed Feb. 9, 2018
- HealthInvest Partners AB 2017 Q3 filed Nov. 13, 2017
- HealthInvest Partners AB 2017 Q2 filed Aug. 7, 2017
- HealthInvest Partners AB 2017 Q1 filed April 28, 2017
- HealthInvest Partners AB 2016 Q4 filed Jan. 24, 2017